BioArctic AB banner

Company Overview

Business Description

Sector
Health Care
Industry
Biotechnology
Headquarters
Sweden SE
Employees
49
IPO date
Oct 12, 2017

BioArctic is a Swedish drug company focused on treatments for neurodegenerative diseases, especially Alzheimer’s disease and Parkinson’s disease. It does not run a broad consumer business; instead, it discovers and develops medicines and then partners with larger pharmaceutical companies to test, manufacture, and sell them. Its best-known work is around antibody-based drugs that target harmful proteins in the brain.

The company makes money mainly through research payments, milestone payments, and royalties tied to partner-led drug programs. In practice, BioArctic earns income when a partner advances one of its drug candidates, wins approvals, or sells the medicine in the market. That makes it more of a research-and-license business than a traditional drug maker with its own large sales force.

What makes BioArctic different is its strong focus on hard-to-treat brain diseases and its role as an inventor rather than a full commercial pharmaceutical company. It helps create the science and drug candidates, while bigger partners handle late-stage development and global distribution. For investors, the key idea is that BioArctic’s value comes from its pipeline and from how well its partnered medicines perform in the market.

BioArctic AB Investor Relations

Address
Warfvinges vag 35
Stockholm
Sweden

Business Segments

Partnered drug programs

BioArctic develops antibody medicines for brain diseases and works with larger drug companies to take them through testing and approval. Its best-known work is in Alzheimer’s disease, where it helped create lecanemab wit...

Customers and revenue model

Early-stage research

BioArctic also runs its own research to find new antibody treatments for neurodegenerative diseases and build the science behind future drug candidates.

Customers and revenue model

Management

Dr. Gunilla Osswald Ph.D.

President & CEO

Biography unavailable

Dr. Pär Gellerfors

Co-Founder, Senior VP of Business Strategy & Director

Biography unavailable

Prof. Lars Lannfelt

Co-Founder, Senior VP of Medical science & Director

Biography unavailable

Mr. Anders Martin-Lof M.B.A., M.Sc.

Chief Financial Officer

Biography unavailable

Ms. Johanna Fälting

Chief Research Officer & Head of Research

Biography unavailable

Mr. Christer Möller

VP of Pre-Clinical Development & Chief Scientific Officer

Biography unavailable

Mr. Oskar Bosson

VP and Head of IR & Communication

Biography unavailable

Mr. Leif Gallo LL.M.

General Counsel and Head of Legal & IP

Biography unavailable

Mr. Harald Borgeke

Head of Public Affairs

Biography unavailable

Ms. Frida Lekander

Head of Marketing

Biography unavailable

1 / 10